Study of FHIT transcripts in normal and malignant breast tissue

Genes Chromosomes and Cancer

Volumn 23, Issue 4, 1998, Pages 292-299

  Bièche, Ivan ^a   Latil, Alain ^a   Becette, Véronique ^a   Lidereau, Rosette ^a  

^a CENTRE RENÉ HUGUENIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CHROMOSOME 3P; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ISOLATION; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; BREAST NEOPLASMS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE ANALYSIS, DNA;

EID: 0344193089     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199812)23:4<292::AID-GCC3>3.0.CO;2-E     Document Type: Article

References (34)

1. Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF (1997) Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial cancer probands. Cancer Res 57:3664-3668.
2. Ali IU, Lidereau R, Callahan R (1989) Presence of two members of c-erbA receptor gene family (c-erbAβ and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-3p25 in human breast cancer. J Natl Cancer Inst 81:1815-1820.
3. Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov MR, Klinger H, Drabkin HA (1997) Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Human Mol Genet 2:193-203.
4. Buchhagen DL, Qiu L, Etkind P (1994) Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3-3p21.3 in sporadic breast-cancer development. Int J Cancer 57:473-479.
5. Bugert P, Wilhelm M, Kovacs G (1997) FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosomes Cancer 20:9-15.
6. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-ehloroform extraction. Anal Biochem 162:156-159.
7. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS (1979) Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med 301:592-595.
8. Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K, Smith HS (1994) Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 54:499-505.
9. Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli G, Inoue H, Croce CM, Huebner K (1997) Structure and expression of the human FHIT gene in normal and tumor cell. Cancer Res 57:504-512.
10. Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Ader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD (1997) FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res 57:2256-2267.
11. Glover TW, Berger C, Coyle J, Echo B (1984) DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67:136-142.
12. Hayashi SI, Tanimoto K, Hajiro-Nakanishi K, Tsuchiya E, Kurosumi M, Higashi Y, Imai K, Suga K, Nakachi K (1997) Abnormal FHIT transcripts in human breast carcinomas: A clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res 57:1981-1985.
13. Hendricks DT, Taylor R, Reed M. Birrer MJ (1997) FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res 57:2112-2115.
14. 4-tetraphosphate (Ap4A) asymmetrical hydrolase: Sequence similarity with the histidine triad (HIT) family. Biochem J 312:925-932.
15. Kastury K, Baffa R, Druck T, Ohta M, Coticelli MG, Inoue H, Negrini M, Rugge M, Huang D, Croce CM, Palazzo J, Huebner K (1996) Potential gastrointestinal tumor suppressor locus at 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res 56:978-983.
16. Li I, Francke V, Cohen SN (1997) The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88:143-154.
17. Lisitsyn NA, Lisitsina NM, Dalbagni G, Barker P, Sanchez CA, Gnarra J, Linchan WM, Reid BJ, Wigler MH (1995) Comparative genomic analysis of tumors: Detection of DNA losses and amplification. Proc Natl Acad Sci USA 92:151-155.
18. Man S, Ellis IO, Sibbering M, Blamey RW, Brook JD (1996) High levels of allele loss at the FHIT and ATM genes in noncomedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res 56:5484-5489.
19. Mao L, Fan YH, Lotan R, Hong WK (1996) Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 56:5128-5131.
20. Matsumoto S, Kasumi E Sakamoto G, Onda M, Nakamura Y, Emi M (1997) Detailed deletion mapping of chromosome arm 3p in breast cancers: A 2-cM region on 3p 14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors. Genes Chromosomes Cancer 20:268-274.
21. Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM (1996) The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56:3173-3178.
22. Ohta M, Inoue H, Coticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
23. Panagopoulos I, Pandis N, Thelin S, Peterson C, Mertens F, Borg A, Kristoffcrsson U, Mitelman F, Aman P (1996) The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer cytogenetic rearrangements of chromosome band 3p14. Cancer Res 56:4871-4875.
24. Panagopoulos I, Thelin S, Mertens F, Mitelman F, Aman P (1997) Variable FHIT transcript in nonneoplastic tissues. Genes Chromosomes Cancer 19:215-219.
25. Pandis N, Bardi G, Mitelman F, Heim S (1997) Deletion of the short arm of chromosome 3 in breast tumors. Genes Chromosomes Cancer 18:241-245.
26. Rodriguez E, Sreekantaiah C, Chaganti RSK (1994) Genetic changes in epithelial solid neoplasia. Cancer Res 54:3398-3406.
27. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y (1991) Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51:5794-5799.
28. Sigalas I, Calvcrt AH, Anderson JJ, Neal DE, Lunec J (1996) Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer. Nat Genet 2:912-917.
29. Sozzi G, Veronese ML, Negrini M, Baffa R, Coticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino IT, Pierotti MA, Ohta M, Huehner K, Croce CM (1996) The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85:17-26.
30. Thiagalingam S, Lisitsyn NA, Hamagushi M, Wigler MH, Willson JKV, Markowitz SD, Leach FS, Kinzler KW. Vogelstein B (1996) Evaluation of the FHIT gene in colorectal cancers. Cancer Res 56:2936-2939.
31. van den Berg A, Draaijers TG, Kok K, Timmer T, Van der Veen AY, Veldhuis PMJF, de Leij L, Gerhartz CD, Naylor SL, Smith DI, Buys CHCM (1997) Normal FHIT transcripts in renal cell cancerand lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region. Genes Chromosomes Cancer 19:220-227.
32. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, Croce CM (1996) FHIT gene alterations in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 93:9770-9775.
33. Yanagisawa K, Kondo M, Osada H, Uchida K, Takagi K, Masuda A, Takahashi T, Takahashi T (1996) Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Cancer Res 56:5579-5582.
34. Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM. Popescu NC, Huebner K (1997) Positions of chromosome 3pl4.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res 57:1166-1170.